Effects of κ- and μ-opioid receptor agonists on Ca2+ channels in neuroblastoma cells: Involvement of the orphan opioid receptor

European Journal of Pharmacology

Volumn 379, Issue 2-3, 1999, Pages 191-198

  Hurlé, María A ^a   Sánchez, Ana ^b   García Sancho, Javier ^b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Ca2+ channels; Dihydropyridine; Nociceptin; Opioid receptor; Orphanin FQ

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; CALCIUM CHANNEL; DIHYDROPYRIDINE DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NALTREXONE; NOCICEPTIN; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; PERTUSSIS TOXIN; SUFENTANIL;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; DRUG EFFECT; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

ANALGESICS, OPIOID; CALCIUM CHANNELS, L-TYPE; HUMANS; NEUROBLASTOMA; OPIOID PEPTIDES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TUMOR CELLS, CULTURED;

EID: 0345008868     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00469-0     Document Type: Article

References (36)

1. 2+ channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur. J. Pharmacol. 137:1987;9-13.
2. 2+ channels. Brain Res. 672:1995;148-152.
3. Baumhaker Y., Gafni M., Keren O., Sarne Y. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 44:1993;461-467.
4. 2+ channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br. J. Pharmacol. 88:1986;561-567.
5. 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. J. Neurochem. 65:1995;170-175.
6. Cheng Z.J., Fan G.H., Zhao J., Zhang Z., Wu Y.L., Jiang L.Z., Zhu Y., Ma L. Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells, activation of inhibitory G protein and homologous desensitization. Neuroreport. 8:1997;1913-1918.
7. 2+ in the SH-SY5Y human neuroblastoma cell line. Br. J. Pharmacol. 118:1996;205-207.
8. 2+ during opioid tolerance and supersensitivity in rats. J. Pharmacol. Exp. Ther. 274:1995;1538-1544.
9. Díaz A., Ruiz F., Flórez J., Hurlé M.A., Pazos A. μ opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. J. Pharmacol. Exp. Ther. 274:1995;1545-1551.
10. 2+ channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;559-565.
11. 2+ channel modulation by dihydropyridines modifies sufentanil-induced respiratory depression in cats. Eur. J. Pharmacol. 198:1991;149-155.
12. Fawzi A.B., Zhang H., Weig B., Hawes B., Graziano M.P. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells, functional homology with opioid receptors. Eur. J. Pharmacol. 336:1997;233-242.
13. 2+ uptake in three neuronal cell lines. Brain Res. 687:1995;94-102.
14. 2+ current of mouse dorsal root ganglion neurons in cell culture. Proc. Natl. Acad. Sci. U.S.A. 84:1987;5469-5473.
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
16. Guerrini R., Calo G., Rizzi A., Bigoni R., Bianchi C., Salvadori S., Regoli D. A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol. 123:1998;163-165.
17. 2+ agonists and antagonists of the dihydropyridine type: antinociceptive effects, interference with opiate-μ-receptor agonists and neuropharmacological actions in rodents. Psychopharmacology. 90:1986;299-307.
18. 3H norepinephrine release in the human neuroblastoma cell line SK-N-SH Brain Res. 646:1994;319-323.
19. Knoflach F., Reinscheid R.K., Civelli O., Kemp J.A. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci. 16:1996;6657-6664.
20. Meunier J.-C., Mollerau C., Toll L., Saudreau C., Moisand C., Alvinerie P., Butour J.-L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Permentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
21. o-type GTP-binding protein. J. Neurosci. 14:1994;3842-3851.
22. North, R.A., 1993. Opioid actions on membrane ion channels. In: Herz, A., Akil, H., Simon, E. (Eds.), Handbook of Experimental Pharmacology: Opioids I. Springer-Verlag, Berlin, pp. 773-797.
23. Ramkumar V., El-Fakahany E.E. Prolonged morphine treatment increases rat brain dihydropyridine-binding sites: possible involvement in development of morphine dependence. Eur. J. Pharmacol. 146:1988;73-83.
24. 2+ channels in the nucleus tractus solitarius of the rat. J. Neurosci. 14:1994;7608-7615.
25. 2+ antagonist nimodipine in awake rats. Naunyn Scmied. Arch. Pharmacol. 348:1993;633-637.
26. Santillán R., Maestre J.M., Hurlé M.A., Flórez J. Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine. A preliminary report. Pain. 58:1994;129-132.
27. Santillán R., Hurlé M.A., Armijo J.A., de los Mozos R., Flórez J. Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study. Pain. 76:1998;17-26.
28. 2+ currents, but spares a sustained current. Neuron. 6:1991;13-20.
29. 2+ channel current. Proc. R. Soc. London, B. 244:1991;129-135.
30. 2+ currents by noradrenaline, somatostatin and opioids in guinea pig submucosal neurons. J. Physiol. 431:1990;585-608.
31. i in ND8-47 neuroblastoma X dorsal root ganglion hybrid cells is mediated through G protein-coupled δ-opioid receptors and desensitized by chronic exposure to opioid. J. Neurochem. 65:1995;1612-1621.
32. 2+ entry into GH3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers. FASEB J. 6:1992;2742-2747.
33. Wu, Y.L., Pu, L., Ling, K., Zhao, J., Cheng, Z.J., Ma, L., Pei, G., 1997. Molecular characterisation and functional expression of opioid receptor-like1 receptor.
34. Yin D.L., Ren X.H., Zheng Z.L., Pu L., Jiang L.Z., Ma L., Pei G. Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: involvement of pertussis toxin-sensitive G proteins. Neurosci. Res. 29:1997;121-127.
35. Yu V.C., Richards M.L., Sadee W. A human neuroblastoma cell line expresses μ- and δ-receptor sites. J. Biol. Chem. 261:1986;1065-1070.
36. Zhang S., Yu L. Identification of dynorphins as endogenous ligands for an opioid receptor-like orphan receptor. J. Biol. Chem. 270:1995;22772-22776.